Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing Breast Cancer

NCT06492447 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

HER 2 Low-expressing Breast Cancer

Interventions

DRUG: Against HER 2-ADC Drug

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

[object Object]